Evidence map›Paper›PMID 32709717›Full record

ArticleLife science alliance2020

Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1

Alistair Lj Symonds, Wei Zheng, Tizong Miao, Haiyu Wang, TieShang Wang, Ruth Kiome, Xiujuan Hou, Suling Li, Ping Wang

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Nanomaterials Trigger Functional Anti-Tumoral Responses in Primary Human Immune Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alistair Lj SymondsThe Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-9461-0816
Wei ZhengDivision of Rheumatology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China.ORCID 0000-0002-1741-7537
Tizong MiaoThe Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Haiyu WangDivision of Rheumatology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China.
TieShang WangDivision of Rheumatology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Ruth KiomeBioscience, Brunel University, Uxbridge, UK.
Xiujuan HouDivision of Rheumatology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China houxiujuan2008@163.com.ORCID 0000-0002-1236-6849
Suling LiBioscience, Brunel University, Uxbridge, UK su-ling.li@brunel.ac.uk.ORCID 0000-0001-8756-9336
Ping WangThe Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK p.wang@qmul.ac.uk.ORCID 0000-0001-8992-1233
Beijing University of Chinese Medicine · CNQueen Mary University of London · GBBrunel University of London · GB

Funding

Medical Research Council MR/N00096X/1
6 · The paper itself

Abstract

The transcription factors Egr2 and 3 are essential for controlling inflammatory autoimmune responses of memory phenotype (MP) CD4 T cells. However, the mechanism is still unclear. We have now found that the Egr2

Indexed as

AnimalsAntigens, CDAutoimmunityCD4-Positive T-LymphocytesCell DifferentiationCell ProliferationEarly Growth Response Protein 2Early Growth Response Protein 3FemaleHomeostasisInflammationLymphocyte ActivationMaleMiceMice, Inbred C57BLProgrammed Cell Death 1 ReceptorAntigens, CDEarly Growth Response Protein 2Early Growth Response Protein 3Egr2 protein, mouseEgr3 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID32709717
PMCPMC7391068
OpenAlexW3045271823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.